This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: after renal transplantation, but many will continue to have a degree of residual hyperparathyroidism (tertiary hyperparathyroidism) post-transplant with associated risk of bone loss, etc. Tertiary: The basis of treatment is still prevention in chronic renal failure, starting medication and dietary restrictions long before dialysis treatment is initiated. Cinacalcet has greatly reduced the number of patients who ultimately require surgery for secondary hyperparathyroidism; however, approximately 5% of patients do not respond to medical therapy. If the patient fails to respond to medical treatment, the treatment of choice is surgical removal of three and one half parathyroid glands. Prognosis The prognosis is dependent on the successful treatment of the underlying cause. Prevention As with many conditions, prevention is dependent on early identification of the underlying cause....
View Full Document
- Fall '10